Literatur
Burge PS, Jones PW, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320:1297
Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J. 2002;19(1):182–91
Worth H, Buhl R, Criée P et al. The ‘real-life’ COPD patient in Germany: The DACCORD study. Respir Med. 2016;111:64–71
Magnussen H, Disse B, Rodriguez-Roisin R et al. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD. N Engl J Med. 2014;371:1285–94
Originalie
Chapman KR, Hurst JR, Frent SM et al. Long-term Triple Therapy De-escalation to Indacaterol/ Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple- Dummy Clinical Trial. Am J Respir Crit Care Med. 2018;198(3):329–39
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Zeeuw, J. Aus drei mach zwei — Deeskalation oder Korrektur beim Inhalieren?. Pneumo News 10, 12–13 (2018). https://doi.org/10.1007/s15033-018-0972-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-018-0972-1